FDA Inspection
VKT Pharma Private LimitedVKT Pharma Private Limited – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns VKT Pharma Private Limited, with an inspection on February 7, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 2c515a76-cf4b-4557-891b-65c821e176d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1260195
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of VKT Pharma Private Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 25, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for VKT Pharma Private Limited
- FDA Inspection 1119188 - 2020-02-28
- FDA Inspection 1057019 - 2018-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.